StockTitan
banner
stocktitan.net
StockTitan
@stocktitan.net
Stock News Live - https://www.stocktitan.net/
Pinned
Stock Titan uses AI and technology to deliver easy access to the stock market most valuable asset: Actionable Information

Explore real-time stock market news with our Live Feed www.stocktitan.net/news/live.html

Find trading opportunities with our Momentum Scanner www.stocktitan.net/scanner/mome...
Stock Market News Live Feed | Stock Titan
Stay ahead with the Live Feed for real-time US stock market news, updates, and press releases. Ideal for traders and investors seeking instant access to market-moving information
www.stocktitan.net
#CRML Critical Metals Corp to Deploy Fully Autonomous Communications and Drone System at Tanbreez Rare Earth Project in Greenland

https://www.stocktitan.net/news/CRML/critical-metals-corp-to-deploy-fully-autonomous-communications-and-3z5chtb5ckd0.html
Critical Metals Corp to Deploy Fully Autonomous Communications and Drone System at Tanbreez Rare Earth Project in Greenland
Critical Metals Corp (NASDAQ: CRML) will deploy a fully autonomous Nexus 20 communications tower and integrated drone system at its Tanbreez rare earth project in Greenland, with deployment scheduled for May 2026. The Nexus 20 is custom-engineered for Arctic conditions and will provide continuous radio and emergency communications, 360-degree optical surveillance, and an autonomous drone remotely operated from Perth for real-time imaging and geological reconnaissance. Critical Metals will also receive a fully integrated medical, emergency, and accommodation site package fabricated in Thailand to support remote field teams. The system is intended to improve operational safety, accelerate exploration, and increase transparency for investors.
www.stocktitan.net
January 27, 2026 at 3:30 PM
#INMB INmune Bio Inc Issues Shareholder Letter Reviewing 2025 Milestones and Outlining 2026 Strategic Initiatives

https://www.stocktitan.net/news/INMB/i-nmune-bio-inc-issues-shareholder-letter-reviewing-2025-milestones-m6sdtzaztb4i.html
INmune Bio Inc Issues Shareholder Letter Reviewing 2025 Milestones and Outlining 2026 Strategic Initiatives
INmune Bio (NASDAQ: INMB) CEO David Moss reviewed 2025 progress and outlined 2026 priorities, highlighting clinical and regulatory milestones for two lead programs: CORDStrom for recessive dystrophic epidermolysis bullosa (RDEB) and XPro (XPro1595) for Alzheimer’s disease. Key 2025 items include three commercial pilot-scale manufacturing runs for CORDStrom, a planned MAA submission in mid‑summer 2026 to the UK MHRA and a targeted BLA submission late 2026 to FDA (timelines subject to regulatory feedback). XPro’s Phase 2 MINDFuL showed biomarker‑defined signals (EMACC effect size 0.27) guiding a precision‑medicine registrational path. Cash and equivalents were approximately $27.7M as of Sept 30, 2025, with financing and rebates expected to fund operations through year‑end 2026.
www.stocktitan.net
January 27, 2026 at 2:25 PM